Health
New ‘SINT1A‘ study explores potential of a probiotic to prevent type 1 diabetes in children – News-Medical.Net
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until…
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until severe and sometimes life-threatening symptoms have already developed. The new ‘SINT1A‘ study explores the potential of a specific probiotic to strengthen the immune system early-on in children with increased genetic risk of type 1 diabetes, and thus prevent its development.
SINT1A is led by Helmholtz Zentrum Muenchen, and part of the…
-
General23 hours agoWest Indies vs Australia live: Second Test, day two from Grenada
-
Business18 hours agoAre electric vehicle stocks a good investment today?
-
Noosa News15 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
General12 hours agoGwalia resident works to save century-old home in ‘living ghost town’